Cancer Support Group

Wednesday, Apr 14th

Last update:06:42:40 AM GMT

Home News and Update Year 2010 Aspirin Offers no Protection Against Skin Cancer

Aspirin Offers no Protection Against Skin Cancer

Aspirin Offers no Protection Against Skin Cancer Aspirin Offers no Protection Against Skin Cancer
The use of non–steroidal anti–inflammatory drugs such as aspirin, ibuprofen and celecoxib offer no protection against a common skin cancer, according to a new study.

Non–steroidal anti–inflammatory drugs (NSAIDs) reduce pain and inflammation by blocking an enzyme involved in producing inflammatory compounds.

Maryam M. Asgari, of Kaiser Permanente Northern California, Oakland, and colleagues studied 415 health plan members who were diagnosed with squamous cell carcinoma in 2004 and 415 control patients who were the same age, (Bleep) and race but had no history of skin cancer. Participants completed a questionnaire about NSAID use in the 10 years prior.

The majority of participants (61 per cent) reported regular use of NSAIDs within the previous ten years, including 48 per cent who used aspirin, 18 per cent who used ibuprofen, 5 per cent who used naproxen and 4 per cent who used nabumetone.

“Regular use of any NSAID was not associated with a reduction in squamous cell carcinoma risk. Although NSAID users whose exposure was of short duration (one to three years) appeared to be at somewhat increased risk for squamous cell carcinoma, we found no consistent effects of duration of use of any NSAID on squamous cell carcinoma risk,” the authors said.

Squamous cell carcinoma risk also did not appear to change regardless of NSAID dose, whether the medications were administered by a pharmacy nor with any individual type of NSAID medication.

The study will appear in the April print issue of Archives of Dermatology, one of the JAMA/Archives journals.

Times of India
16 February, 2010

Disclaimer: The news story on this page is the copyright of the cited publication. This has been reproduced here for visitors to review, comment on and discuss. This is in keeping with the principle of ‘Fair dealing’ or ‘Fair use’. Visitors may click on the publication name, in the news story, to visit the original article as it appears on the publication’s website.


This is YOUR sites, so if you have suggestions or feedback on how we can improve it for you, please let us know! We do our best to keep up!

Make a Suggestion
Manthan Award

Link to Aarogya

aarogya logo